Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients
- PMID: 30754934
- PMCID: PMC6481971
- DOI: 10.23876/j.krcp.18.0045
Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients
Abstract
Background: The objective of this study was to compare the impact of citrate dialysate (CD) and standard acetate dialysate (AD) in hemodialysis by central delivery system (CDS) on heparin demand, and clinical parameters.
Methods: We retrospectively evaluated 75 patients on maintenance hemodialysis with CDS. Patients underwent hemodialysis with AD over a six-month period (AD period), followed by another six-month period using CD (CD period). Various parameters including mean heparin dosage, high sensitivity C-reactive protein (hsCRP), calcium-phosphate product (CaxP), intact parathyroid hormone (iPTH), and urea reduction ratio (URR) were collated at the end of each period.
Results: Patients were 60.5 ± 14.7 years old, of whom 62.7% were male. Patients required less heparin when receiving CD (AD period: 1,129 ± 1,033 IU/session vs. CD period: 787 ± 755 IU/session, P < 0.001). After the CD period (ΔCD), pre-dialysis total CO2 increased to 1.21 ± 2.80 mmol/L, compared to -2.44 ± 2.96 mmol/L (P < 0.001) after the AD period (ΔAD). After the CD period, concentrations of iPTH (ΔAD: 73.04 ± 216.34 pg/mL vs. ΔCD: -106.66 ± 251.79 pg/mL, P < 0.001) and CaxP (ΔAD: 4.32 ± 16.63 mg2/dL2 vs. ΔCD: -4.67 ± 15.27 mg2/dL2, P = 0.015) decreased. While hsCRP levels decreased after the CD period (ΔAD: 0.07 ± 4.09 mg/L vs. ΔCD: -0.75 ± 4.56 mg/L, P = 0.705), the change was statistically insignificant. URR remained above clinical guideline of 65% after both periods (ΔAD: 72.33 ± 6.92% vs. ΔCD period: 69.20 ± 4.49%, P = 0.046).
Conclusion: Our study confirmed that the use of CD in CDS required lower heparin doses compared to the use of AD. The use of CD also provided a more stable acid-base status.
Keywords: Acetates; Citric acid; Hemodialysis; Heparin.
Conflict of interest statement
All authors have no conflicts of interest to declare.
Figures
Similar articles
-
Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study.Int J Nephrol Renovasc Dis. 2021 Dec 24;14:475-486. doi: 10.2147/IJNRD.S340028. eCollection 2021. Int J Nephrol Renovasc Dis. 2021. PMID: 34992426 Free PMC article.
-
Improvements in Inflammation and Calcium Balance of Citrate versus Acetate as Dialysate Buffer in Maintenance Hemodialysis: A Unicentric, Cross-Over, Prospective Study.Blood Purif. 2021;50(6):914-920. doi: 10.1159/000513419. Epub 2021 Feb 3. Blood Purif. 2021. PMID: 33535212
-
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.Clin Biochem. 2014 Sep;47(13-14):1316-9. doi: 10.1016/j.clinbiochem.2014.06.009. Epub 2014 Jun 21. Clin Biochem. 2014. PMID: 24956265
-
Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study.Hemodial Int. 2016 Oct;20(4):537-547. doi: 10.1111/hdi.12433. Epub 2016 Jun 20. Hemodial Int. 2016. PMID: 27325599 Clinical Trial.
-
Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.BMC Nephrol. 2009 Mar 5;10:7. doi: 10.1186/1471-2369-10-7. BMC Nephrol. 2009. PMID: 19265544 Free PMC article. Clinical Trial.
Cited by
-
Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication.Korean Circ J. 2021 Dec;51(12):961-982. doi: 10.4070/kcj.2021.0995. Korean Circ J. 2021. PMID: 34854578 Free PMC article. Review.
-
Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study.Int J Nephrol Renovasc Dis. 2021 Dec 24;14:475-486. doi: 10.2147/IJNRD.S340028. eCollection 2021. Int J Nephrol Renovasc Dis. 2021. PMID: 34992426 Free PMC article.
-
Switching from acetate to citrate dialysate in a central concentrate delivery system for high-volume online hemodiafiltration: a retrospective cohort study.Ren Fail. 2024 Dec;46(2):2398709. doi: 10.1080/0886022X.2024.2398709. Epub 2024 Sep 9. Ren Fail. 2024. PMID: 39252176 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials